Hormonal Contraceptive Use Among Adolescent Girls in Germany in Relation to Health Behavior and Biological Cardiovascular Risk Factors

• Published in: Journal of adolescent health Vol. 48; no. 4; pp. 331 - 337
• Main Authors: Du, Yong, Ph.D, Rosner, Bettina M., Ph.D., M.P.H, Knopf, Hildtraud, M.D, Schwarz, Sabine, Ph.D, Dören, Martina, M.D, Scheidt-Nave, Christa, M.D., M.P.H
• Format: Journal Article
• Language: English
• Published: New York, NY Elsevier Inc 01.04.2011; Elsevier
• Subjects: Adolescent; Adolescent girls; Adolescents; Biological and medical sciences; Blood pressure; Cardiovascular diseases; Cardiovascular Diseases - epidemiology; Cardiovascular risk; Children; contraceptives; Contraceptives, Oral, Hormonal - therapeutic use; Developmental psychology; Female; Fundamental and applied biological sciences. Psychology; Germany; Germany - epidemiology; Health Behavior; Health risks; Health Surveys; Health-related behavior; Hormonal contraceptives; Humans; Lipids; Obesity; Pediatrics; Proteins; Psychology. Psychoanalysis. Psychiatry; Psychology. Psychophysiology; Risk assessment; Risk Factors; Risk-Taking; Sensitivity; Sociodemographic aspects; Europe; Germany; Hormonal contraceptives; Adolescents; Cardiovascular risk; Health-related behavior; Human; Adolescent; Risk factor; Health behavior; Female; Cardiovascular disease; Contraception
• ISSN: 1054-139X; 1879-1972
• DOI: 10.1016/j.jadohealth.2011.01.004

Abstract Purpose To determine the association between hormonal contraceptive (HC) use, and behavior-related and biological cardiovascular risk factors among teenage girls in Germany. Methods HC use was assessed among 2,285 girls aged 13–17 years who participated in the health survey for children and adolescents (German Health Interview and Examination Survey for Children and Adolescents, KiGGS), between years 2003 and 2006. Prevalence of HC use was determined according to sociodemographic variables, behavior-related health risks, and overweight status. We compared HC users and nonusers with respect to biological cardiovascular risk factors, including systolic and diastolic blood pressure, and serum concentrations of lipids, lipoproteins, high sensitivity C-reactive protein (hs-CRP), and homocysteine. Results HC users were more likely than nonusers to combine several behavior-related health risks, independent of sociodemographic factors. In particular, HC use was strongly associated with current smoking (odds ratio: 3.4, 95% confidence interval: 2.7–4.3). HC use and behavioral factors showed an additive effect on biological cardiovascular risk factors, explaining between 6% and 30% of the population variance. Relative contributions of HC use ranged from <1% for systolic and diastolic blood pressure to 12% for hs-CRP. Conclusions HC use among 13–17-year-old girls in Germany is significantly correlated with a more unfavorable cardiovascular risk profile, which is partly explained by a clustering of behavioral risk factors among HC users. When prescribing HC to teenagers, physicians should systematically assess avoidable behavioral cardiovascular risk factors and provide counseling tailored to the risk profile of the individual patient.